Critical dependence of blood-borne biomarker concentrations on the half-lives of their carrier proteins

Journal of Theoretical Biology

Volumn 253, Issue 3, 2008, Pages 616-622

  Araujo, R P ^a   Petricoin, E F ^a   Liotta, L A ^a  

^a GEORGE MASON UNIVERSITY   (United States)

Author keywords

Diagnostic biomarkers; Mass action kinetics; Proteomics; Serum

Indexed keywords

BIOLOGICAL MARKER; CARRIER PROTEIN; NANOPARTICLE;

BIOMARKER; BLOOD; CONCENTRATION (COMPOSITION); DETECTION METHOD; DISEASE; HALF LIFE; NUMERICAL MODEL; PROTEIN; SERUM;

ARTICLE; BLOOD FLOW; CIRCULATION; MATHEMATICAL MODEL; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; CARRIER PROTEINS; HALF-LIFE; HUMANS; KIDNEY; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEOME;

MOPS;

EID: 46849109305     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2008.04.009     Document Type: Article

References (21)

1. Anderson L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J. Physiol. 563 1 (2005) 23-60
2. Anderson N.L., and Anderson N.G. The human plasma proteome-history, character, and diagnostic prospects. Mol. Cell. Proteomics 1 11 (2002) 845-867
3. Anderson N.L., Polanski M., Pieper R., Gatlin T., Tirumalai R.S., Conrads T.P., Veenstra T.D., Adkins J.N., Pounds J.G., Fagan R., and Lobley A. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 3 4 (2004) 311-326
4. Corot C., Violas X., Robert P., Gagneur G., and Port M. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol. Invest. Radiol. 38 (2003) 311-319
5. Dennis M.S., Zhang M., Meng Y.G., Kadkhodayan M., Kirchofer D., Combs D., and Damico L.A. Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J. Biol. Chem. 277 (2002) 35035-35043
6. Diamandis E.P., and van der Merwe E. Plasma protein profiling by mass spectrometry for cancer diagnosis: opportunities and limitations. Clin. Cancer Res. 11 (2005) 963-965
7. Ding Y., Lin B., and Huie C.W. Binding studies of porphyrins to human serum albumin using affinity capillary electrophoresis. Electrophoresis 22 (2001) 2210-2216
8. Dufour C., and Dangles O. Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy. Biochim. Biophys. Acta 1721 (2005) 164-173
9. Etzioni R., Urban N., Ramsey S., McIntosh M., Schwartz S., Reid B., Radich J., Anderson G., and Hartwell L. The case for early detection. Nat. Rev. Cancer 3 (2003) 1-9
10. Geho D.H., Garaci E., Belluco C., Petricoin E.F., and Liotta L.A. Nanotechnology in clinical proteomics. Nanomedicine 2 (2007) 1-5
11. Kiviat N.B., and Critchlow C.W. Novel approaches to identification of biomarkers for detection of early stage cancer. Dis. Markers 18 (2002) 73-81
12. Klasko, R.K. (Ed.), 2000. United States Pharmacopoeia DI, vol. 1 of Drug information for the health care professional. United States Pharmacopeial Convention, Inc., Greenwood Village, CO.
13. Liotta L.A., Ferrari M., and Petricoin E.F. Written in blood. Nature 425 (2003) 905
14. Luchini A., Geho D.H., Bishop B., Tran D., Xia C., Dufour R.L., Jones C.D., Espina V., Patanarut A., Zhou W., Ross M.M., Tessitore A., Petricoin E.F., and Liotta L.A. Smart hydrogen particles: biomarker harvesting: one-step affinity purification, size exclusion and protection against degradation. Nano Lett. 8 (2008) 350-361
15. Mehta A.I., Ross S., Lowenthal V., Fusaro M.S., Fishman D.A., Petricoin E.F., and Liotta L.A. Biomarker amplification by serum carrier protein binding. Dis. Markers 19 1 (2003) 1-10
16. Merrell K., Southwick K., Graves S.W., Esplin M.S., Lewis N.E., and Thulin C.D. Analysis of low-abundance, low-molecular-weight serum proteins using mass spectrometry. J. Biomol. Tech. 15 4 (2004) 238-248
17. Petricoin E.F., and Liotta L.A. Proteomic approaches in cancer risk and response assessment. Trends Mol. Med. 10 2 (2004) 59-64
18. Petricoin E.F., and Liotta L.A. Seldi-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr. Opin. Biotechnol. 15 (2004) 24-30
19. Reed R.G., Feldhoff R.C., Clute O.L., and Peters T. Fragments of bovine serum albumin produced by limited proteolysis: conformation and ligand binding. Biochemistry 14 (1975) 4578-4583
20. Srinivas P.R., Kramer B.S., and Srivastava S. Trends in biomarker research for cancer detection. Lancet 2 (2001) 698-704
21. Tirumalai R.S., Chan K.C., Prieto D.A., Issaq H.J., Conrads T.P., and Veenstra T.D. Characterisation of the low molecular weight human serum proteome. Mol. Cell. Proteomics 2 10 (2003) 1096-1103